TwitterFacebookGoogle+LinkedInPinterest

Archive for the ‘Nurse Practitioners’ Category

Potential ‘Universal’ Blood Test For Cancer Discovered

The Lymphocyte Genome Sensitivity (LGS) test looks at white blood cells and measures the damage caused to their DNA when subjected to different intensities of ultraviolet light (UVA), which is known to damage DNA. The results of the empirical study show a clear distinction between the damage to the white blood cells from patients with cancer, with pre-cancerous conditions and from healthy patients. (Stock image).
Source: © RFsole / Fotolia

Researchers from the University of Bradford have devised a simple blood test that can be used to diagnose whether people have cancer or not. The test will enable doctors to rule out cancer in patients presenting with certain symptoms, saving time and preventing costly and unnecessary invasive procedures such as colonoscopies and biopsies being carried [...]

New Device Detects Deadly Lung Disease

The lateral-flow device (LFD) detects invasive pulmonary aspergillosis, a notoriously difficult to diagnose disease caused by the fungus Aspergillus. Source: University of Exeter

A scientist from the University of Exeter has developed a simple, cheap and highly accurate device for diagnosing a frequently fatal lung disease which attacks immune deficient individuals such as cancer patients and bone marrow transplant recipients. The lateral-flow device (LFD), created by Professor Chris Thornton, detects invasive pulmonary aspergillosis, a notoriously difficult to diagnose [...]

Total Darkness At Night Key To Success Of Breast Cancer Therapy, Study Shows

Principal investigators and co-leaders of Tulane's Circadian Cancer Biology Group, Steven Hill (left) and David Blask (right), and team members Robert Dauchy and Shulin Xiang.
Source: Paula Burch-Celentano, Tulane University

Exposure to light at night, which shuts off nighttime production of the hormone melatonin, renders breast cancer completely resistant to tamoxifen, a widely used breast cancer drug, says a new study by Tulane University School of Medicine cancer researchers. The study, “Circadian and Melatonin Disruption by Exposure to Light at Night Drives Intrinsic Resistance to [...]

Drug Approved To Treat Rare Disorder Associated With Anesthesia

“When a patient experiences malignant hyperthermia during surgery, it is a life‐threatening emergency requiring immediate treatment including the administration of the ‘antidote’ drug dantrolene sodium,” said Henry Rosenberg, MD, CPE, a founder and President of the Malignant Hyperthermia Association of the United States (MHAUS). “The ability for healthcare professionals in hospitals and surgery centers to more quickly prepare and administer this new formulation of the antidote dantrolene sodium is expected to bring the crisis under control more rapidly and prevent severe complications from MH.” Source: MHAUS

Eagle Pharmaceuticals, Inc. today announced the US Food and Drug Administration (FDA) has approved Ryanodex® (dantrolene sodium) for injectable suspension indicated for the treatment of malignant hyperthermia (MH), along with the appropriate supportive measures. MH is an inherited and potentially fatal disorder triggered by certain anesthesia agents in genetically susceptible individuals. FDA had designated Ryanodex [...]

‘Heartless’ Patient Discharged From Hospital

onald Fontana is discharged home while he waits for a matching donor heart transplant. He is enjoying his family, thanks to the SynCardia Total Artificial Heart powered by the Freedom Portable Driver. Source: Syracuse.com

A central New York recipient of a SynCardia temporary Total Artificial Heart implant is home, discharged from University of Rochester’s Strong Memorial Hospital with the Freedom® portable driver to wait for a matching donor heart. Fontana, a 64-year-old retiree from a Syracuse architectural hardware company, suffered from heart disease—cardiomyopathy—for decades. He managed the condition with [...]